Mögele, T.; Höck, M.; Sommer, F.; Friedrich, L.; Sommer, S.; Schmutz, M.; Altenburger, A.; Messmann, H.; Anthuber, M.; Kröncke, T.;
et al. Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial). Cancers 2024, 16, 4173.
https://doi.org/10.3390/cancers16244173
AMA Style
Mögele T, Höck M, Sommer F, Friedrich L, Sommer S, Schmutz M, Altenburger A, Messmann H, Anthuber M, Kröncke T,
et al. Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial). Cancers. 2024; 16(24):4173.
https://doi.org/10.3390/cancers16244173
Chicago/Turabian Style
Mögele, Tatiana, Michael Höck, Florian Sommer, Lena Friedrich, Sebastian Sommer, Maximilian Schmutz, Amadeus Altenburger, Helmut Messmann, Matthias Anthuber, Thomas Kröncke,
and et al. 2024. "Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial)" Cancers 16, no. 24: 4173.
https://doi.org/10.3390/cancers16244173
APA Style
Mögele, T., Höck, M., Sommer, F., Friedrich, L., Sommer, S., Schmutz, M., Altenburger, A., Messmann, H., Anthuber, M., Kröncke, T., Stüben, G., Trepel, M., Märkl, B., Dintner, S., & Claus, R.
(2024). Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial). Cancers, 16(24), 4173.
https://doi.org/10.3390/cancers16244173
